Despite safety concerns, clozapine has a unique profile of clinical benefits in patients with treatment-resistant schizophrenia or schizophrenia-associated suicidality

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 10, 2007-10 ,pp. : 9-13

Adis International

Access to resources Recommend Favorite

The relative prescribing rate of atypical antipsychotics for patients with schizophrenia and other psychotic disorders "nearly doubled" in general practice between 1998 and 2002

By  

Inpharma, Vol. 1, Iss. 1389, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Informed Consent and Antipsychotic Use in Patients with Schizophrenia: Issues and Recommendations

By Laugharne J.  

CNS Drugs, Vol. 9, Iss. 1, 1998-01 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Valproate Use in Children and Adolescents with Bipolar Disorder

By Jean Michel Azorin   Findling Robert L.  

CNS Drugs, Vol. 21, Iss. 12, 2007-01 ,pp. : 1019-1033

Adis International

Access to resources Recommend Favorite

Validity and Consistency of Self-Reports Regarding Substance Use in General Research Volunteers, Including Regular Cannabis Users and Schizophrenia Patients

By Kedzior Karina   Badcock Johanna   Martin-Iverson Mathew  

Substance Use & Misuse, Vol. 41, Iss. 5, 2006-05 ,pp. : 743-750

Informa Healthcare

Access to resources Recommend Favorite